Quick answers
- What is Haloperidol used for?
- The FDA-approved label (Haloperidol, Remedyrepack Inc., August 31, 2026) says: “Haloperidol tablets are indicated for use in the management of manifestations of psychotic disorders. Haloperidol tablets are indicated for the control of tics and vocal utterances of Tourette's Disorder in children and adults. Haloperidol tablets are effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Haloperidol have a boxed warning?
- Yes. The FDA label for Haloperidol has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Haloperidol?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Haloperidol been recalled?
- FDA enforcement reports list 2 recalls of products of this medicine; the newest started October 10, 2025 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Haloperidol?
- 33 companies list prescription products of Haloperidol in the FDA NDC Directory, including Bryant Ranch Prepack, Remedyrepack Inc. and Method Pharmaceuticals, LLC.
What Haloperidol is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Haloperidol tablets are indicated for use in the management of manifestations of psychotic disorders. Haloperidol tablets are indicated for the control of tics and vocal utterances of Tourette's Disorder in children and adults. Haloperidol tablets are effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). …
— FDA label: Haloperidol, Remedyrepack Inc., effective August 31, 2026. Read the full label on DailyMed →
The FDA has 83 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Read it on the full label →
82 of 83 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet · Injection, solution · Solution · Injection · Solution, concentrate |
|---|---|
| Route | Oral · Intramuscular |
| Prescription products | 175 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| haloperidol 0.5 mg tablet | Generic | $0.0914 per tablet |
| haloperidol 1 mg tablet | Generic | $0.1354 per tablet |
| haloperidol 10 mg tablet | Generic | $0.1475 per tablet |
| haloperidol 2 mg tablet | Generic | $0.1779 per tablet |
| haloperidol 2 mg/mL solution | Generic | $0.1765–$0.6517 per mL 2 packages, lowest to highest |
| haloperidol 2 mg/mL solution, concentrate | Generic | $0.1765–$0.6517 per mL 2 packages, lowest to highest |
| haloperidol 20 mg tablet | Generic | $0.3595 per tablet |
| haloperidol 5 mg tablet | Generic | $0.1711 per tablet |
| haloperidol lactate 2 mg/mL solution | Generic | $0.1765–$0.6517 per mL 2 packages, lowest to highest |
| haloperidol lactate 5 mg/mL injection | Generic | $0.7792 per mL |
| haloperidol lactate 5 mg/mL injection, solution | Generic | $0.7792 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack26 products
- Remedyrepack Inc.13 products
- Method Pharmaceuticals, LLC12 products
- Coupler LLC10 products
- PD-Rx Pharmaceuticals, Inc.6 products
- AiPing Pharmaceutical, Inc.6 products
- Aurobindo Pharma Limited6 products
- Zydus Lifesciences Limited6 products
- Zydus Pharmaceuticals USA Inc.6 products
- Novadoz Pharmaceuticals LLC6 products
- Creekwood Pharmaceuticals LLC6 products
- Upsher-Smith Laboratories, LLC6 products
- Marlex Pharmaceuticals, Inc.6 products
- Ajanta Pharma USA Inc.6 products
- Lifestar Pharma LLC6 products
- Innogenix, Inc.6 products
- Amici Pharmaceuticals LLC6 products
- Mylan Institutional Inc.4 products
- American Health Packaging4 products
- Major Pharmaceuticals4 products
- Cardinal Health 107, LLC4 products
- Mylan Pharmaceuticals Inc.4 products
- Safecor Health LLC3 products
- Hikma Pharmaceuticals USA Inc.3 products
- NCS HealthCare of KY, LLC dba Vangard Labs2 products
- Unit Dose Solutions, Inc.1 product
- PAI Holdings, LLC dba PAI Pharma1 product
- Advagen Pharma Ltd1 product
- HF Acquisition Co LLC, DBA HealthFirst1 product
- Henry Schein, Inc.1 product
- Lannett Company, Inc.1 product
- Mylan Institutional LLC1 product
- Fresenius Kabi USA, LLC1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (16)
- ANDA070278Mylan · June 10, 1986
- ANDA071130Aiping Pharm Inc · February 17, 1987
- ANDA071173Sciegen Pharms · January 7, 1988
- ANDA073037Pharm Assoc · February 26, 1993
- ANDA073364Lannett Co Inc · September 28, 1993
- ANDA075689Fresenius Kabi USA · March 9, 2001
- ANDA075858Hikma · June 18, 2001
- ANDA077580Zydus Pharms USA · November 29, 2007
- ANDA078347Mylan Labs Ltd · September 14, 2009
- ANDA211061Appco · January 8, 2020
- ANDA216004Msn · November 18, 2022
- ANDA218371Rubicon Research · January 31, 2024
- ANDA216918Mankind Pharma · April 11, 2024
- ANDA218789Aurobindo Pharma Ltd · April 19, 2024
- ANDA218162Creekwood Pharms · December 18, 2025
- ANDA218210Ajanta Pharma Ltd · September 14, 2026
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
October 10, 2025 · Class II · Ongoing · D-0214-2026
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health LL — Safecor Health, LLC
-
March 15, 2021 · Class II · Terminated · D-0593-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
HALOPERIDOL TABLETS 20mg, USP, 100-count bottle, Rx Only Distributed by: Usher-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC: 0832-1560-11 — Cardinal Health Inc.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Haloperidol, Remedyrepack Inc., effective August 31, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →